Used in pharmaceutical synthesis as a key intermediate in the development of kinase inhibitors, particularly for targeted cancer therapies. Its structural features enable selective binding to specific enzyme active sites, enhancing drug efficacy. The compound’s fluorinated groups improve metabolic stability and bioavailability in final drug formulations. Also employed in research settings to study structure-activity relationships in fluorinated organic molecules.